ERBB2 and breast carcinoma: We tested a panel of five breast cancer cell (BCC) lines that represented the molecular subtypes of triple-negative breast cancer (TNBC), HER2+, and ER+/PR+, including MB-231, BT20, MCF7, T47D, and ZR75-1.